» Authors » Cherry Chu

Cherry Chu

Explore the profile of Cherry Chu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 40
Citations 370
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chaudhry S, Yazdani S, Chu C, Tharmarajah S, Persaud N, Tadrous M
Can Fam Physician . 2025 Jan; 71(1):43-49. PMID: 39843186
Objective: To understand the possible association between media coverage and changes in the dispensation of doxylamine-pyridoxine in Canada. Design: Cross-sectional time-series analysis using data from the IQVIA CompuScript database. Setting:...
2.
Baxter S, Lund L, Andersen J, Brix T, Hegedus L, Hsieh M, et al.
Thyroid . 2025 Jan; 35(1):69-78. PMID: 39772758
Concerns have been raised that glucagon-like peptide 1 receptor agonists (GLP1-RAs) may increase the risk of thyroid cancer, but evidence remains conflicting. We therefore investigated if GLP1-RA use, compared with...
3.
Khan B, Liu R, Chu C, Bolea-Alamanac B, Nguyen M, Thapar S, et al.
Int J Ment Health Syst . 2024 Nov; 18(1):34. PMID: 39511581
Background: Access to traditional mental health services in Canada remains limited, prompting exploration into digital alternatives. The Government of Ontario initiated access to two internet-based cognitive behavioral therapy (iCBT) programs,...
4.
Chu C, Khan B, Thiruchelvam D, Brual J, Abejirinde I, Kthupi A, et al.
PLoS One . 2024 Oct; 19(10):e0312270. PMID: 39453932
Objective: To describe and compare the characteristics of people with SUD and their use of healthcare services in two ways: 1) across varying levels of marginalization and 2) before and...
5.
Senthinathan A, Tadrous M, Hussain S, Ahmad A, Chu C, Craven B, et al.
Healthcare (Basel) . 2024 Oct; 12(19). PMID: 39408182
Background/objective: The purpose of this study was to investigate the impact of the COVID-19 pandemic on mortality rates in a community-dwelling spinal cord injury (SCI) population in Ontario. Methods: Using...
6.
Saunders K, Shakeri A, Chu C, Drucker A, Tadrous M
Clin Rheumatol . 2024 Aug; 43(10):3083-3088. PMID: 39198358
Janus Kinase (JAK) inhibitors have emerged as a novel category of medications to treat a variety of immune-mediated conditions. However, limited insight exists regarding the impact of safety concerns on...
7.
Khan B, Chu C, Brual J, Dang-Nguyen M, Oladimeji A, Kthupi A, et al.
Psychiatr Serv . 2024 Jul; 76(1):41-48. PMID: 38982834
Objective: Digital substance use treatment programs present an opportunity to provide nonresidential care for people with problematic substance use. In June 2021, the provincial government in Ontario provided free access...
8.
Senthinathan A, Tadrous M, Hussain S, McKay S, Moineddin R, Chu C, et al.
Spinal Cord . 2024 May; 62(7):406-413. PMID: 38811768
Study Design: Descriptive repeated-cross sectional retrospective longitudinal cohort study. Objective: To investigate the impact of the COVID-19 pandemic on homecare services in individuals with traumatic or non-traumatic Spinal Cord Injury...
9.
Limerick A, McCabe E, Turner J, Kuang K, Brautigan D, Hao Y, et al.
bioRxiv . 2024 May; PMID: 38798407
Mutations in human (ciliogenesis associated kinase 1) are linked to ciliopathies and epilepsy. Homozygous point and nonsense mutations that extinguish kinase activity impair primary cilia function, whereas mutations outside the...
10.
Naveed Z, Chu C, Tadrous M, Veroniki A, Li J, Rouleau I, et al.
Heliyon . 2024 Mar; 10(5):e26551. PMID: 38439866
Objective: To compare myocarditis/pericarditis risk after COVID-19 mRNA vaccination versus SARS-CoV-2 infection, and to assess if myocarditis/pericarditis risk varies by vaccine dosing interval. Methods: In this retrospective cohort study, we...